|
Sex and Age
|
|
Female, n/N (%)
|
237/566 (41.9)
|
|
Age years, median (IQR)
|
62 (45;74)
|
|
Charlson Comorbidity Index
|
|
0, n/N (%)
|
161/566 (28.4)
|
|
1–2, n/N (%)
|
138/566 (24.4)
|
|
3–4, n/N (%)
|
159/566 (28.1)
|
|
≥ 5, n/N (%)
|
108/566 (19.1)
|
|
Antiplatelet/−coagulant treatment
|
|
Yes, n/N (%)
|
144/556 (25.9)
|
|
- Acetylsalicylic acid, n/N (%)
|
65/144 (45.1)
|
|
- ADP-receptor antagonist, n/N (%)
|
32/144 (22.2)
|
|
- Vitamin K antagonist, n/N (%)
|
18/144 (12.5)
|
|
- NOAC, n/N (%)
|
32/144 (22.2)
|
|
No, n/N (%)
|
412/556 (74.1)
|
|
Trauma Mechanism
|
|
Traffic, n/N (%)
|
143/557 (25.6)
|
|
Fall < 2 m, n/N (%)
|
350/557 (62.8)
|
|
Fall > 2 m, n/N (%)
|
17/557 (3.1)
|
|
Violence, n/N (%)
|
14/557 (2.5)
|
|
Other, n/N (%)
|
33/557 (5.9)
|
|
Alcohol/drugs prior to trauma
|
|
Suspected, n/N (%)
|
161/521 (30.9)
|
|
Not suspected, n/N (%)
|
360/521 (69.1)
|
|
GCS at inclusion
|
|
GCS 15
|
453/566 (80.0)
|
|
GCS 14
|
113/566 (20.0)
|
